The global ENT devices market size is expected to reach USD 23.1 billion by 2022, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.0% during the forecast period. Rising geriatric population and increasing prevalence of ENT related disorders are the primary factors stoking the growth of the market.
According to WHO, 33.0% of geriatric population and 15.0% of adult population worldwide suffer from hearing disordersBesides this, in 2015, 13,560 new cases were registered according to the National Cancer Institute. Increasing cases of hearing disorders are estimated to increase the usage of hearing devices.
Technological advancements and user-friendly ENT devices are further projected to drive the industry. For instance, use of thermoplastic material for development of nasal splints is gaining demand. Developing economies such as South Africa, Brazil, China, and India are anticipated to provide significant opportunities for the growth of the market due to unmet healthcare needs coupled with presence of target population.
Hearing aids were the largest segment in 2016. Rising target population, high accessibility, and significantly high usage are the key factors contributing to the growth of the market. The hearing implants segment is likely to witness fast growth during the forecast period due to introduction of technologically advanced devices and soaring rate of patient compliance overcoming social stigma towards use of such devices.
Cochlear implant is one of the largest segments of the hearing implants market. Growing customization in cochlear implants is the major factor responsible for its higher usage
North America dominated the market in terms of revenue in 2016, due to presence of well-established healthcare infrastructure, favorable government initiatives, and high awareness levels of practitioners and patients
Asia Pacific is projected to be the fastest growing region over the forecast period and it's due to favorable government policies, rising levels of healthcare expenditure, improving healthcare infrastructure, and clinical advancements in product development
Major players are introducing novel devices to increase their market share. For instance, HiQ+ series of bipolar endoscopes by Olympus Medical Systems and Soundbridge by MED-EL.
Browse related reports by Grand View Research:
Top 10 Drug Delivery Technologies Market - Introduction of advanced technologies such as novel intelligent inhalers and micro-needle transdermal patches is one of the high impacts rendering driver for top 10 drug delivery technologies market.
Grand View Research has segmented the global ENT devices market on the basis of product, and region:
ENT Devices Product Outlook (Revenue, USD Million, 2012 - 2022)
Diagnostic Ear, Nose, And Throat (ENT) Devices
Robot Assisted Endoscope
Hearing Screening Device
Surgical Ear, Nose, And Throat (ENT) Devices
Powered Surgical Instrument
Otological Drill Burrs
ENT Hand Instruments
Sinus Dilation Devices
Nasal Packing Devices
Hearing Aids Ear, Nose, And Throat (ENT) Devices
Behind-the-Ear (BTE) aids
Canal hearing aids ITC, CIC and IIC
Hearing Implants Ear, Nose, And Throat (ENT) Devices
Auditory Brainstem Implants
Middle Ear Implants
Bone Anchored Hearing System
Nasal Splints Ear, Nose, And Throat (ENT) Devices
Internal Nasal Splints
External Nasal Splints
ENT DevicesRegional Outlook (Revenue, USD Million, 2012 - 2022)
Middle East & Africa
Explore the BI enabled intuitive market research database,The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org